BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 427324)

  • 1. The effect of pargyline and desmethylimipramine on monoamine concentrations and amphetamine-induced glycogenolysis in the mouse brain.
    Hutchins DA
    Br J Pharmacol; 1979 Mar; 65(3):489-94. PubMed ID: 427324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of methylenedioxymethamphetamine with monoamine transmitter release mechanisms in rat brain slices.
    Fitzgerald JL; Reid JJ
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):313-23. PubMed ID: 8097569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain.
    Hutchins DA; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):19-29. PubMed ID: 4269287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. D-amphetamine-induced hydrogen peroxide production in skeletal muscle is modulated by monoamine oxidase inhibition.
    Duarte JA; Carvalho F; Fernandes E; Remião F; Bastos ML; Magalhães J; Appell HJ
    Int J Sports Med; 2004 Aug; 25(6):446-9. PubMed ID: 15346233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of (+) amphetamine on monoamine synthesis and metabolism after axotomy in rat forebrain.
    Speckenbach W; Kehr W
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec; 296(1):25-30. PubMed ID: 1087702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of inhibition of monoamine uptake by cocaine, methylphenidate and amphetamine.
    Taylor D; Ho BT
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):67-75. PubMed ID: 684280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trace amines inhibit the electrically evoked release of [3H]acetylcholine from slices of rat striatum in the presence of pargyline: similarities between beta-phenylethylamine and amphetamine.
    Baud P; Arbilla S; Cantrill RC; Scatton B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):220-9. PubMed ID: 3930699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP4 on central noradrenaline neurons.
    Hallman H; Jonsson G
    Eur J Pharmacol; 1984 Aug; 103(3-4):269-78. PubMed ID: 6237924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of imipramine, desipramine and monoamine oxidase inhibitors on the metabolism and psychomotor stimulant actions of d-amphetamine in mice.
    Lew C; Iversen SD; Iversen LL
    Eur J Pharmacol; 1971 May; 14(4):351-9. PubMed ID: 4400534
    [No Abstract]   [Full Text] [Related]  

  • 10. Depletion of brain noradrenaline and dopamine by 6-hydroxydopamine.
    Breese GR; Traylor TD
    Br J Pharmacol; 1971 May; 42(1):88-99. PubMed ID: 5580702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of amphetamine on brain biogenic amines in isolated and aggregated rats.
    Lokiec F; Jacquot C; Rapin JR; Cohen Y
    Eur J Pharmacol; 1977 Aug; 44(4):391-5. PubMed ID: 891613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of amphetamine and apomorphine on brain monoamines and behaviour in the immature and young adult rat.
    Lal S; Feldmüller F
    Arch Int Pharmacodyn Ther; 1975 Dec; 218(2):239-51. PubMed ID: 1212022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of central catecholamine alterations on the hypothermic response to 6-hydroxydopamine in desipramine treated rats.
    Breese GR; Howard JL
    Br J Pharmacol; 1971 Nov; 43(3):671-4. PubMed ID: 5157728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of brain monoamines in the fatal hyperthermia induced by pethidine or imipramine in rabbits pretreated with a monoamine oxidase inhibitor.
    Gong SN; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):12-8. PubMed ID: 4269286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-Methoxytyramine and normetanephrine as indicators of dopamine and noradrenaline release in mouse brain in vivo.
    Kehr W
    J Neural Transm; 1981; 50(2-4):165-78. PubMed ID: 7241115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of receptor blocking drugs on the depletion of brain glycogen by amphetamine.
    Hutchins DA; Rogers KJ
    Br J Pharmacol; 1971 Nov; 43(3):504-13. PubMed ID: 4400527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective (+)-amphetamine neurotoxicity on striatal dopamine nerve terminals in the mouse.
    Jonsson G; Nwanze E
    Br J Pharmacol; 1982 Oct; 77(2):335-45. PubMed ID: 7139192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The importance of neuronal uptake of amines for amphetamine-induced release of 3H-norepinephrine from isolated brain tissue.
    Azzaro AJ; Ziance RJ; Rutledge CO
    J Pharmacol Exp Ther; 1974 Apr; 189(1):110-8. PubMed ID: 4823286
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of reserpine on body temperature in the rat after pretreatment with amphetamine and monoamineoxidase inhibitors.
    Cremades A; Serrano JS; Jané F; Milanés MV
    Methods Find Exp Clin Pharmacol; 1982; 4(8):563-8. PubMed ID: 7169843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]8-OH-DPAT binding and serotonin content in rat cerebral cortex after acute fluoxetine, desipramine, or pargyline.
    Carli M; Afkhami-Dastjerdian S; Reader TA
    J Psychiatry Neurosci; 1996 Mar; 21(2):114-22. PubMed ID: 8820177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.